AG NPP709 is at present available on the market; however, no review has investigated the result of AG NPP709 in people with COPD. Hence, the goal of the analyze was To judge the efficacy of AG NPP709 in patients with Long-term bronchitis kind COPD.Berberine suppresses inflammatory brokers-induced interleukin-1beta and tumor necrosis factor-alpha pr